Keyphrases
Type I Diabetes
100%
Core Outcome Set
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Randomized Controlled Trial
66%
Clinical Trials
36%
Pertuzumab
33%
Pulmonary Medicine
33%
Respiratory Medicine
33%
Reporting Guidelines
33%
Risk Outcomes
33%
Patient Outcomes
33%
Risk-benefit
33%
Trial Registration
33%
Patient Benefit
33%
Drug Development
33%
Web-based Survey
33%
Clinical Perspective
33%
Patient Risk
33%
Clinical Trial Registry
29%
Breast Cancer
19%
Trialists
12%
Objective Response Rate
11%
Descriptive Statistics
9%
Inferential Statistics
9%
Adverse Events
8%
PRISMA
8%
Trial Adherence
8%
Equator
8%
Off-label Use
8%
PRISMA-P
8%
EQUATOR Network
8%
Instructions to Authors
8%
CHEERS
8%
Top 100
8%
Overall Survival
8%
Inclusion Criteria
6%
Patient Care
6%
FDA-approved Drugs
5%
Evidence-based Practice
5%
Inconsistency
5%
Clinical Research
5%
Severe Hypoglycemia
5%
Hemoglobin A1c (HbA1c)
5%
Financial Burden
5%
Health Burden
5%
Clinical Endpoints
5%
Medicine and Dentistry
Clinical Trial
47%
Cross Sectional Study
33%
Randomized Controlled Trial
33%
Insulin Dependent Diabetes Mellitus
33%
Respiratory Medicine
33%
Pertuzumab
33%
Breast Cancer
19%
Overall Survival
11%
Adverse Event
8%
Off-Label Use
8%
Hypoglycemia
6%
Clinical Research
6%
Hemoglobin A1c
6%
Independent Reviewer
6%